FIELD: veterinary biochemistry, biochemistry of bony tissue.
SUBSTANCE: the present innovation deals with evaluating the activity of osteogenesis due to carrying out biochemical blood testing in the course of which it is necessary to detect the levels of total calcium, inorganic phosphate, magnesium and chlorine content (C) in blood serum during regeneration of diaphysial fractures of tubular bones without phenomenon of distraction to calculate the index of electrolytes (IE) according to the following formula: IE = CCa CMg CCl/CPO4. At its value being above 150 (up to250 and more) one should conclude upon catabolic phase, and at its value being below 150 (up to 110 and less) - anabolic phase of osteogenesis should be stated upon.
EFFECT: higher efficiency of control.
1 ex, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR EVALUATING INTEGRATION OF BONE REPLACEMENT MATERIAL IN EXPERIMENT | 2019 |
|
RU2715283C1 |
| METHOD FOR DETERMINING REPARATIVE DOG OSTEOGENESIS ENERGY SUPPLY CONDITIONS | 2004 |
|
RU2274862C2 |
| METHOD FOR TREATING THE CASES OF BONE INJURIES UNDER RETARDED CONSOLIDATION | 2003 |
|
RU2250789C2 |
| 0 |
|
SU1776410A1 | |
| METHOD FOR PREDICTING BONE FORMATION PROCESS DEVELOPMENT IN TREATING THE CASES OF FALSE ARTICULATIONS | 2000 |
|
RU2177619C1 |
| PHARMACEUTICAL COMPOSITION 'MYCEPHOSPHONE' FOR STIMULATION OF SUPPORTING TISSUE REGENERATION | 2010 |
|
RU2442592C1 |
| COMPOSITION STIMULATING REPARATIVE OSTEOGENESIS IN DOGS AND CATS | 2022 |
|
RU2785118C1 |
| PHARMACEUTICAL COMPOSITION MYCEOSTIN STIMULATING SUPPORTING TISSUE AND ARTICULAR CARTILAGE REGENERATION (VERSIONS) | 2010 |
|
RU2444365C1 |
| PHARMACOLOGICAL AGENT WITH A DIRECTED ACTION ON THE PROCESSES OF OSSIFICATION AND OSTEOGENESIS IN ANIMALS AND POULTRY | 2022 |
|
RU2797918C1 |
| METHOD OF TREATING MULTI-SPLINTERED AND MULTIPLE FRACTURES OF LONG TUBULAR BONES | 2008 |
|
RU2370227C1 |
